Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

The drug was approved to treat patients who have already received chemotherapy under an accelerated approval process after a ...

Find insight on Doosan Fuel Cell, XRG, Santos and more in the latest Market Talks covering Energy and Utilities.

Stem cell therapies are gradually becoming a viable medical option for a range of health conditions. Today, a micro-cap ...

The Dow plunged Wednesday on a disappointing outlook from the Federal Reserve. In the process, the blue-chip index extended its losing streak to 10 days — the longest such stretch since Gerald ...

Johnson & Johnson said the first clinical data from its ongoing Phase 1b study of JNJ-4496, a chimeric antigen receptor T-cell therapy, shows encouraging potential in treating large B-cell ...

A month ago, UnitedHealth was the highest-priced stock in the Dow — but now its shares have lost more than 50% of their value.. The Dow is up almost 5% in the same period. That's seemingly good ...